2GY Stock Overview
Through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
PHC Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥5.85 |
| 52 Week High | JP¥9.50 |
| 52 Week Low | JP¥5.40 |
| Beta | 0.77 |
| 1 Month Change | 7.34% |
| 3 Month Change | -2.50% |
| 1 Year Change | -37.10% |
| 3 Year Change | -56.02% |
| 5 Year Change | n/a |
| Change since IPO | -71.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2GY | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.8% | 3.0% | 3.0% |
| 1Y | -37.1% | -4.9% | 12.8% |
Return vs Industry: 2GY underperformed the German Medical Equipment industry which returned -4.9% over the past year.
Return vs Market: 2GY underperformed the German Market which returned 12.8% over the past year.
Price Volatility
| 2GY volatility | |
|---|---|
| 2GY Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2GY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2GY's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 9,245 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products.
PHC Holdings Corporation Fundamentals Summary
| 2GY fundamental statistics | |
|---|---|
| Market cap | €745.95m |
| Earnings (TTM) | -€39.40m |
| Revenue (TTM) | €2.24b |
0.3x
P/S Ratio-19.2x
P/E RatioIs 2GY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2GY income statement (TTM) | |
|---|---|
| Revenue | JP¥360.94b |
| Cost of Revenue | JP¥196.83b |
| Gross Profit | JP¥164.11b |
| Other Expenses | JP¥170.45b |
| Earnings | -JP¥6.34b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -50.23 |
| Gross Margin | 45.47% |
| Net Profit Margin | -1.76% |
| Debt/Equity Ratio | 211.0% |
How did 2GY perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield-78%
Payout RatioDoes 2GY pay a reliable dividends?
See 2GY dividend history and benchmarks| PHC Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 66 days |
| Days until Dividend pay date | 157 days |
Does 2GY pay a reliable dividends?
See 2GY dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 14:29 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PHC Holdings Corporation is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |
| Akinori Ueda | Goldman Sachs |